Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingel Demedts

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION StudyMyung-Ju Ahn, Igor Bondarenko, Ewa Kalinka, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2024
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trialLuis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2022
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancerAnne Sibille, Frederique Bustin, Luciano Carestia, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitalsKurt G Tournoy, Michiel Thomeer, Paul Germonpré, et al.
Cancers|August 29, 2018
A Multicenter Study to Assess <i>EGFR</i> Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical SettingLaure Sorber, Karen Zwaenepoel, Koen De Winne, et al.
Frontiers in Immunology|March 20, 2026
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patientsSeverine Planel, Guillaume Vayssière, Gianni Maggipinto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR TrialSolange Peters, Sarah Danson, Baktiar Hasan, et al.
International Journal of Molecular Sciences|April 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy AnalysisOliver Illini, Felix Carl Saalfeld, Petros Christopoulos, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION StudyMyung-Ju Ahn, Igor Bondarenko, Ewa Kalinka, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2024
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trialLuis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2022
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancerAnne Sibille, Frederique Bustin, Luciano Carestia, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitalsKurt G Tournoy, Michiel Thomeer, Paul Germonpré, et al.
Cancers|August 29, 2018
A Multicenter Study to Assess <i>EGFR</i> Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical SettingLaure Sorber, Karen Zwaenepoel, Koen De Winne, et al.
Frontiers in Immunology|March 20, 2026
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patientsSeverine Planel, Guillaume Vayssière, Gianni Maggipinto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR TrialSolange Peters, Sarah Danson, Baktiar Hasan, et al.
International Journal of Molecular Sciences|April 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy AnalysisOliver Illini, Felix Carl Saalfeld, Petros Christopoulos, et al.
Pageof 3